A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2004
12/09/2004	CA2527759A1 Use of s1p
12/09/2004	CA2527309A1 Use of protein associated with mye (pam) to treat pain
12/09/2004	CA2526883A1 A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor .alpha.
12/09/2004	CA2526530A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004	EP1484333A1 New aminopropylphosphonous acids
12/08/2004	EP1484332A2 Lipid-based drug delivery system for administration of a drug substance
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1484061A1 Drugs containing riboflavin-type compounds
12/08/2004	EP1484054A1 Drug delivery system for the subconjunctival administration of fine grains
12/08/2004	EP1483384A2 Method for overexpression of zwitterionic polysaccharides
12/08/2004	EP1483374A2 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483261A1 Phthalimide carboxylic acid derivatives
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482960A2 Methods and products for oral care
12/08/2004	EP1482959A1 Compositions and methods for treatment of skin disorders
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482936A1 Ophthalmic composition comprising ascomycin
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482927A1 Method of treating osteoarthritis
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482787A2 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1303290A4 Small peptides and methods for downregulation of ige
12/08/2004	EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
12/08/2004	EP1224164B1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
12/08/2004	EP1168934A4 Hydrogel-forming system with hydrophobic and hydrophilic components
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1121354B1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h 3 agonists or antagonists
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	CN2661188Y Acesodyne plaster
12/08/2004	CN2661187Y Plaster administered device for lumbago
12/08/2004	CN1553911A Pyrrole derivatives, their preparation and their therapeutic uses
12/08/2004	CN1553905A Novel urea compounds as vanilloid receptor antagonist for treatment of pains
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552725A Preparation of solanine sulfurate and its use in medicine
12/08/2004	CN1552724A Preparation of solanine and its use in medicine
12/08/2004	CN1552710A Use of aspergillus fumigatus in antiflammation immunosuppressant
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552427A Plaster for treating tumour and tuberculosis etc. diseases
12/08/2004	CN1552424A Chinese medicine for treating hair root imflammation of hair line
12/08/2004	CN1552405A Clearing heat and detoxicating medicine
12/08/2004	CN1552399A Rheumatic liquid for treating rheumatism
12/08/2004	CN1552391A Anti-inflammation and antipyretic medicine for treating SARS
12/08/2004	CN1552383A Zuanshanfeng pills and their preparation
12/08/2004	CN1552380A Four season three-yellow micro-pills and their preparation
12/08/2004	CN1552373A Pills for preventing osteoproliferation and preparing method thereof
12/08/2004	CN1552372A Pills against gynecologic inflammation and their preparation
12/08/2004	CN1552371A Flower red pills and their preparation
12/08/2004	CN1552368A Fuyankang pills against gynecologic inflammation and their preparation
12/08/2004	CN1552364A Xuefu ecchymosis eliminating pills and their preparation
12/08/2004	CN1552362A Muscle relaxing pills and their preparation
12/08/2004	CN1552355A Rue extract preparing method
12/08/2004	CN1179034C Healthy medicinal spirit
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178931C Substituted pyrazole compounds
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178914C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178695C Oxidized thymosin beta 4
12/08/2004	CN1178671C Egg anti-inflammatory composition and isolation method and use
12/08/2004	CN1178658C Process for synthesizing Cox-2 inhibitors
12/08/2004	CN1178656C Pharmaceutical composition
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828440 Analgesics; side effect reduction

1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 1272